Page last updated: 2024-10-21

hydroxyindoleacetic acid and Motor Neuron Disease

hydroxyindoleacetic acid has been researched along with Motor Neuron Disease in 2 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Motor Neuron Disease: Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, K1
Namba, R1
Hayabara, T1
Kashihara, K1
Morimoto, K1
Forrest, V1
Ince, P1
Leitch, M1
Marshall, EF1
Shaw, PJ1

Other Studies

2 other studies available for hydroxyindoleacetic acid and Motor Neuron Disease

ArticleYear
Autonomic nervous disorder in motor neuron disease: a study of advanced stage patients.
    Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:10

    Topics: Aged; Autonomic Nervous System Diseases; Biogenic Monoamines; Carboxylic Acids; Dopamine beta-Hydrox

1995
Serotonergic neurotransmission in the spinal cord and motor cortex of patients with motor neuron disease and controls: quantitative autoradiography for 5-HT1a and 5-HT2 receptors.
    Journal of the neurological sciences, 1996, Volume: 139 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Binding, Competitive; Dopamine Agonists; Frontal Lo

1996